Globus Medical (GMED) Accounts Payables (2016 - 2026)
Globus Medical filings provide 15 years of Accounts Payables readings, the most recent being $98.9 million for Q4 2025.
- On a quarterly basis, Accounts Payables rose 31.6% to $98.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.9 million, a 31.6% increase, with the full-year FY2025 number at $98.9 million, up 31.6% from a year prior.
- Accounts Payables hit $98.9 million in Q4 2025 for Globus Medical, up from $87.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $98.9 million in Q4 2025 to a low of $1.5 million in Q2 2023.
- Median Accounts Payables over the past 5 years was $45.2 million (2023), compared with a mean of $48.5 million.
- Biggest five-year swings in Accounts Payables: crashed 95.6% in 2023 and later skyrocketed 4362.66% in 2024.
- Globus Medical's Accounts Payables stood at $22.0 million in 2021, then skyrocketed by 64.43% to $36.1 million in 2022, then surged by 56.98% to $56.7 million in 2023, then soared by 32.55% to $75.1 million in 2024, then surged by 31.6% to $98.9 million in 2025.
- The last three reported values for Accounts Payables were $98.9 million (Q4 2025), $87.2 million (Q3 2025), and $87.1 million (Q2 2025) per Business Quant data.